Calidad de vida en pacientes con cáncer de pulmón

Andrés  Yepes Pérez

doi:10.51643/22562915.377

Calidad de vida en pacientes con cáncer de pulmón

Quality of life in patients with lung cancer

Publicado 2021-10-01

Abrir | Descargar

PDF FLIP

Cómo citar

1.

Yepes Pérez A. Calidad de vida en pacientes con cáncer de pulmón. Rev. colomb. hematol. oncol. [Internet]. 2021 Oct. 1 [cited 2025 Dec. 5];8(1):7-9. https://doi.org/10.51643/22562915.377

Descargar cita

Citaciones

Citas en Crossref

Citas en Scopus

Citas en Google Sholar

Número

Vol. 8 Núm. 1 (2021): Enero-Junio

Sección

Editorial

Cómo citar

1.

Yepes Pérez A. Calidad de vida en pacientes con cáncer de pulmón. Rev. colomb. hematol. oncol. [Internet]. 2021 Oct. 1 [cited 2025 Dec. 5];8(1):7-9. https://doi.org/10.51643/22562915.377

DOI

https://doi.org/10.51643/22562915.377

Dimensions

PlumX

Licencia

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.

Andrés Yepes Pérez

Hospital Universitario de San Vicente Fundación

Roles:

Escritura, revisión y edición

https://orcid.org/0000-0002-7732-333X

Mostrar biografía de los autores

Calidad de vida

cáncer de pulmón

Visitas del artículo 1438 | Visitas PDF 933

Descargas

Los datos de descarga todavía no están disponibles.

World Health Organization [Internet]. Lyon: International Agency for Research on Cancer. The Global Cancer Observatory. World fact sheet: Cancer; 2021 March [Consultado 9 agosto 2021]; Disponible en: http://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf.
Howlader N, Krapcho M, Miller D, et al. SEER cancer statistics review, 1975-2016 [November 2018 SEER data submission posted to the SEER web site, April 9, 2020]. Bethesda, MD: National Cancer Institute. Disponible en: https://seer.cancer.gov/csr/1975_2016/
Koller M, Shamieh O, Hjermstad MJ, et al. European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group; EORTC Lung Cancer Group; European Society of Thoracic Surgeons. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study. Lancet Oncol. [Internet]. 2020;21(5):723-732. Disponible en: https://doi.org/10.1016/S1470-2045(20)30093-0
Ward EM, Sherman RL, Henley SJ, et al. Annual report to the nation on the status of cancer, featuring cancer in men and women age 20-49 years. J Natl Cancer Inst. [Internet]. 2019;111:1279-1297. Disponible en: https://doi.org/1093/jnci/djz106
Hardtstock, F., Myers, D., Li, T. et al. Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis. BMC Cancer. [Internet]. 2020;20:260-274. Disponible en: https://doi.org/10.1186/s12885-020-06738-z
Polanski J, Jankowska-Polanska B, Rosinczuk J, Chabowski M, Szymanska-Chabowska A. Quality of life of patients with lung cancer. Onco Targets Ther. [Internet]. 2016;9:1023-1028. Disponible en: https://doi.org/10.2147/OTT.S100685
Lemonnier I, Guillemin F, Arveux P, Clément-Duchêne C, Velten M, Woronoff-Lemsi MC, et al. Quality of life after the initial treatments of nonsmall cell lung cancer: a persistent predictor for patients’ survival. Health Qual Life Outcomes. [Internet]. 2014;12:73. Disponible en: https://doi.org/10.1186/1477-7525-12-73
Van Der Weijst L, Lievens Y, Schrauwen W and Surmont V. Health-Related Quality of Life in Advanced Non-small Cell Lung Cancer: A Methodological Appraisal Based on a Systematic Literature Review. Front. Oncol. [Internet]. 2019;9:715. Disponible en: https://doi.org/10.3389/fonc.2019.00715
Reale ML, Di Maio M. Quality of life in patients with lung cancer: the way forward. Lancet Oncol. [Internet]. 2020;21:617-619. Disponible en: https://doi.org/10.1016/S1470-2045(20)30151-0
Iyer S, Taylor-Stokes G, Roughley A. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany. Lung Cancer. [Internet]. 2013;81(2):288–293. Disponible en: https://doi.org/10.1016/j.lungcan.2013.03.008
Bdira B, Aissa S, Houda R, Benzarti W, Knaz A, Hayouni A, Abdelghani A, Garrouch A, Benzarti M, Gargouri I. Factors associated with altered quality of life among lung cancer patients. Eur Respir J. [Internet]. 2019;54 (suppl 63) PA4655. Disponible en: https://doi.org/10.1183/13993003.congress-2019.PA4655
Bezjak A, Tu D, Seymour L, et al. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21. J Clin Oncol. [Internet]. 2006;24:3831–3837. Disponible en: https://doi.org/10.1200/JCO.2006.05.8073
Reck M, Wehler T, Orlandi F, et al. Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer. J Clin Oncol. [Internet]. 2020;38:2530-2542. Disponible en: https://doi.org/10.1200/JCO.19.03158
Hazell SZ, Fu W, Hu C, Voong KR, Lee B, Peterson V, Feliciano JL, Nicholas LH, McNutt TR, Han P, Hales RK. Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life. Ann Oncol. [Internet]. 2020;31(1):96-102. Disponible en: https://doi.org/10.1016/j.annonc.2019.10.006
Ramsey S, Bansal A, Fedorenko C, et al. Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol. 2016;34(9):980e986. Disponible en: https://doi.org/10.1200/JCO.2015.64.6620